Piedmont Investment Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Piedmont Investment Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24,588	Closed	-$357K	–	1350
2019 Q1	$357K	Buy	24,588 +2,066	+9%	+$26.4K	0.01%	714
2018 Q4	$249K	Buy	22,522 +4,511	+25%	+$62.8K	0.01%	825
2018 Q3	$474K	Sell	18,011 -54	-0.3%	-$1.46K	0.02%	542
2018 Q2	$369K	Buy	18,065 +1,638	+10%	+$35.1K	0.02%	546
2018 Q1	$298K	Buy	16,427 +726	+5%	+$12.1K	0.01%	574
2017 Q4	$219K	Sell	15,701 -904	-5%	-$12.2K	﹤0.01%	682
2017 Q3	$307K	Buy	16,605 +2,166	+15%	+$36.2K	0.01%	565
2017 Q2	$244K	Buy	+14,439	New	+$220K	0.01%	632

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Piedmont Investment Advisors's MNTA Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 24,588 shares — an estimated $357K sold.

Piedmont Investment Advisors first reported a position in MNTA in Q2 2017 and held it in 8 quarters. The position peaked at $474K in Q3 2018. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

Piedmont Investment Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 24,588 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $357K.
Piedmont Investment Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
Piedmont Investment Advisors's Momenta Pharmaceuticals, Inc. position peaked at $474K in Q3 2018.
155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.